212 related articles for article (PubMed ID: 36064607)
21. Growth patterns in children with mucopolysaccharidosis I and II.
Różdżyńska-Świątkowska A; Jurecka A; Cieślik J; Tylki-Szymańska A
World J Pediatr; 2015 Aug; 11(3):226-31. PubMed ID: 25410665
[TBL] [Abstract][Full Text] [Related]
22. The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).
Harmatz P; Hendriksz CJ; Lampe C; McGill JJ; Parini R; Leão-Teles E; Valayannopoulos V; Cole TJ; Matousek R; Graham S; Guffon N; Quartel A;
Mol Genet Metab; 2017 Sep; 122(1-2):107-112. PubMed ID: 28457718
[TBL] [Abstract][Full Text] [Related]
23. Cumulative incidence rates of the mucopolysaccharidoses in Germany.
Baehner F; Schmiedeskamp C; Krummenauer F; Miebach E; Bajbouj M; Whybra C; Kohlschütter A; Kampmann C; Beck M
J Inherit Metab Dis; 2005; 28(6):1011-7. PubMed ID: 16435194
[TBL] [Abstract][Full Text] [Related]
24. Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose.
Lachman RS; Burton BK; Clarke LA; Hoffinger S; Ikegawa S; Jin DK; Kano H; Kim OH; Lampe C; Mendelsohn NJ; Shediac R; Tanpaiboon P; White KK
Skeletal Radiol; 2014 Mar; 43(3):359-69. PubMed ID: 24389823
[TBL] [Abstract][Full Text] [Related]
25. Widespread abnormalities of radiocolloid distribution in patients with mycopolysaccharidoses.
Klingensmith WC; Eikman EA; Maumenee I; Wanger HN
J Nucl Med; 1975 Nov; 16(11):1002-6. PubMed ID: 810547
[TBL] [Abstract][Full Text] [Related]
26. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia.
Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S
Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975
[TBL] [Abstract][Full Text] [Related]
27. Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III).
Muschol NM; Pape D; Kossow K; Ullrich K; Arash-Kaps L; Hennermann JB; Stücker R; Breyer SR
Orphanet J Rare Dis; 2019 May; 14(1):93. PubMed ID: 31046785
[TBL] [Abstract][Full Text] [Related]
28. Aortic Root Dilatation in Mucopolysaccharidosis I-VII.
Bolourchi M; Renella P; Wang RY
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916847
[TBL] [Abstract][Full Text] [Related]
29. Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review.
Braunlin E; Orchard PJ; Whitley CB; Schroeder L; Reed RC; Manivel JC
Cardiovasc Pathol; 2014; 23(3):145-51. PubMed ID: 24508139
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of bone health in patients with mucopolysaccharidosis.
Kor D; Bulut FD; Kılavuz S; Şeker Yılmaz B; Köşeci B; Kara E; Kaya Ö; Başaran S; Seydaoğlu G; Önenli Mungan N
J Bone Miner Metab; 2022 May; 40(3):498-507. PubMed ID: 35066680
[TBL] [Abstract][Full Text] [Related]
31. Relationships among Height, Weight, Body Mass Index, and Age in Taiwanese Children with Different Types of Mucopolysaccharidoses.
Lin HY; Lee CL; Chiu PC; Niu DM; Tsai FJ; Hwu WL; Lin SJ; Lin JL; Chang TM; Chuang CK; Lin SP
Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31615002
[TBL] [Abstract][Full Text] [Related]
32. [Clinical characteristics of 111 cases with mucopolysaccharidosis ⅣA].
Yi MN; Zhang HW; Gao XL; Wang Y; Han LS; Qiu WJ; Gu XF
Zhonghua Er Ke Za Zhi; 2023 Jun; 61(6):503-508. PubMed ID: 37312460
[No Abstract] [Full Text] [Related]
33. Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis.
McGrath O; Sornalingam K; Aslam T; Ashworth J
Cornea; 2023 Aug; 42(8):992-999. PubMed ID: 36857777
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of oral manifestations of patients with mucopolysaccharidosis IV and VI: clinical and imaging study.
de Almeida-Barros RQ; de Medeiros PFV; de Almeida Azevedo MQ; de Oliveira Lira Ortega A; Yamamoto ATA; Dornelas SKL; Bento PM
Clin Oral Investig; 2018 Jan; 22(1):201-208. PubMed ID: 28315965
[TBL] [Abstract][Full Text] [Related]
35. Challenging behavior in mucopolysaccharidoses types I-III and day-to-day coping strategies: a cross sectional explorative study.
Hoffmann F; Hoffmann S; Kunzmann K; Ries M
Orphanet J Rare Dis; 2020 Oct; 15(1):275. PubMed ID: 33008435
[TBL] [Abstract][Full Text] [Related]
36. [Neurologic manifestations in mucopolysaccharidoses].
Héron B
Arch Pediatr; 2014 Jun; 21 Suppl 1():S14-21. PubMed ID: 25063379
[TBL] [Abstract][Full Text] [Related]
37. Anterior segment OCT imaging in mucopolysaccharidoses type I, II, and VI.
Ahmed TY; Turnbull AM; Attridge NF; Biswas S; Lloyd IC; Au L; Ashworth JL
Eye (Lond); 2014 Mar; 28(3):327-36. PubMed ID: 24384963
[TBL] [Abstract][Full Text] [Related]
38. Estimated birth prevalence of mucopolysaccharidoses in Brazil.
Federhen A; Pasqualim G; de Freitas TF; Gonzalez EA; Trapp F; Matte U; Giugliani R
Am J Med Genet A; 2020 Mar; 182(3):469-483. PubMed ID: 31926052
[TBL] [Abstract][Full Text] [Related]
39. [Echocardiographic findings in 3 cases of mucopolysaccharidosis].
Fujiwara S; Miyamoto Y; Umemoto M; Fukuda K; Yokote Y; Nakamura Y; Masuyama Y
J Cardiogr; 1983 Mar; 13(1):171-80. PubMed ID: 6417249
[TBL] [Abstract][Full Text] [Related]
40. Mental retardation in a patient with Maroteaux-Lamy.
Vestermark S; Tønnesen T; Andersen MS; Güttler F
Clin Genet; 1987 Feb; 31(2):114-7. PubMed ID: 3103957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
